-
Domestic pharmaceutical enterprises are vigorously promoting the construction of industrialization bases, and investment of 100 million yuan has become the norm
Time of Update: 2022-12-30
With the wave of innovation in the pharmaceutical industry, many enterprises are accelerating projects such as building new R&D production bases in order to improve profitability, enhance innovative
-
Global Innovation Index Rankings Released China ranks among the world's top 20 innovative economies
Time of Update: 2022-12-27
” GII 2018 also includes an updated survey of top tech clusters, a new IPC Green List showing a decline in eco-friendly energy-related patents, and new metrics for mobile app creation.
-
26 pharmaceutical and health industry projects landed in Beijing Changping, and the revenue is expected to exceed 72.5 billion yuan in 5 years
Time of Update: 2022-11-25
From the perspective of industrial track, the signed projects include major projects in key tracks with high-growth of cutting-edge technology, mainly including SINOVAC Kexing High-precision Achievement Transformation Base, Wantai Innovative Vaccine Industry Base, Zhuocheng Wison Advanced in Vitro Diagnostic Technology R&D and Transformation Base, Yangtze River Beijing Innovation Center, Kayudi POCT Molecular Diagnosis Production Base, Youbrain Galaxy Brain Science Achievement Research and Industrialization Project, Qi Hesheng Gene Editing Technology R&D Center, etc.
-
Issue 15, 2018 - Dow Singapore Customer Innovation Center opens
Time of Update: 2022-11-11
This strategic move will enhance Dow's innovation capabilities in Southeast Asia and better support local customers and partners.
This strategic move will enhance Dow's innovation capabilities in Southeast Asia and better support local customers and partners.
-
2022CSH focuses on the frontiers of transplantation and explores the way of diagnosis and treatment, and the 17th National Hematology Academic Conference of the Chinese Medical Association
Time of Update: 2022-10-14
Under the co-chairmanship of Professor Wang Fengrong of Peking University People's Hospital and Professor Guo Mei of the Fifth Medical Center of the General Hospital of the People's Liberation Army of Chinese, Professor Sun Yuqian of Peking University People's Hospital deeply interpreted the "Expert Consensus on the Treatment of Blood System Diseases by Allogeneic Hematopoietic Stem Cell Transplantation in China (2021 Updated Edition)".
-
Running into the future: BASF strengthens its investment in shoe materials
Time of Update: 2022-08-17
BASF announced that it will increase investment to strengthen the global shoe material business layout . Newly established shoe material development centers in the United States and Thailand; expecte
-
The rise of deserted beaches petrochemical city
Time of Update: 2021-10-24
Lanzhou Petrochemical Company is a national key project during the "First Five-Year Plan" period and the first modern refining and chemical company after the founding of New China.
-
Coating robots help companies to efficiently produce
Time of Update: 2021-08-19
Global Coatings Network News: In the traditional automotive industry, the paint spraying production line is very wasteful of manpower and material resources, and the production efficiency is relatively low, and the product qualification rate is not high.
-
[Coal Chemical Industry] Shanxi Coking Needs Benefits from All-round Supervision
Time of Update: 2021-06-08
Since the beginning of this year, Shanxi Coking Group Co. , Ltd. has played the role of supervision and inspection, focusing on the key points of supervision, strengthening supervision efficiency, an
-
Lomon Baili creates Asia's largest high-end titanium alloy manufacturer
Time of Update: 2021-05-01
By continuously introducing technology, updating technology, optimizing product structure, and expanding production capacity, Lomon Billion Group has embarked on the road of high-end, green, intelligent, and integrated sustainable development, and has become the leading titanium dioxide enterprise in the country.
-
National Award project Lianhuaqingwen plays an important role in epidemic prevention and control
Time of Update: 2020-02-21
A novel coronavirus pneumonia diagnosis and treatment plan (trial version sixth) was released jointly by the National Health Protection Committee and the State Administration of traditional Chinese me
-
Domestic anti-cancer drugs add a new army! Zhengda Tianqing androtinib was approved. Who is the strong target drug market for lung cancer
Time of Update: 2018-05-15
Recently, the National Drug Administration approved the launch of small molecule and multi-target receptor tyrosine kinase inhibitor androtinib hydrochloride capsule (focovide) for the treatment of ad
-
Gansu printing and distributing the notice of policies and measures to support the development of Longyao industry
Time of Update: 2018-01-17
[policies and regulations of China Pharmaceutical network] the notice on policies and measures to support the development of Gansu medicine industry issued by Gansu Province clearly will accelerate th
